TYPTF (Entropy Neurodynamics) Ending Cash Position: $4.27 Mil (As of Dec. 2025)


What is Entropy Neurodynamics Ending Cash Position?

Entropy Neurodynamics TYPTF Ending Cash Position is $4.27 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Entropy Neurodynamics's Ending Cash Position for the quarter that ended in Dec. 2025 was $4.27 Mil.

Entropy Neurodynamics's quarterly Ending Cash Position increased from Dec. 2024 ($1.82 Mil) to Jun. 2025 ($1.97 Mil) and increased from Jun. 2025 ($1.97 Mil) to Dec. 2025 ($4.27 Mil).

Entropy Neurodynamics's annual Ending Cash Position declined from Jun. 2022 ($3.41 Mil) to Jun. 2023 ($1.10 Mil) but then increased from Jun. 2023 ($1.10 Mil) to Jun. 2025 ($1.97 Mil).

Entropy Neurodynamics Ending Cash Position Related Terms

Entropy Neurodynamics Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Entropy Neurodynamics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entropy Neurodynamics Ending Cash Position Chart

Entropy Neurodynamics Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun25
Ending Cash Position
Get a 7-Day Free Trial 1.20 9.73 3.41 1.10 1.97

Entropy Neurodynamics Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 1.75 1.82 1.97 4.27

Entropy Neurodynamics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Entropy Neurodynamics's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=3.469+-1.499
=1.97

Entropy Neurodynamics's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.011+2.259
=4.27

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $4.27 Mil mean?
Entropy Neurodynamics (TYPTF) has a Ending Cash Position of $4.27 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Entropy Neurodynamics and its competitors.
Is Entropy Neurodynamics' Ending Cash Position too high?
Entropy Neurodynamics' current Ending Cash Position is $4.27 Mil.
How does Entropy Neurodynamics' Ending Cash Position compare to VRTX and REGN?
Entropy Neurodynamics' Ending Cash Position of $4.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Entropy Neurodynamics and its competitors. Entropy Neurodynamics's current Ending Cash Position is $4.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entropy Neurodynamics stock overvalued right now?
Based on GuruFocus' analysis, Entropy Neurodynamics (TYPTF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.02 — trading 100% above its estimated fair value. The current Ending Cash Position is $4.27 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Entropy Neurodynamics (TYPTF), the current Ending Cash Position is $4.27 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entropy Neurodynamics Business Description

Other Exchanges ENP:Australia
Address 117 Camberwell Road,, Hawthorn East, Suite 1.01, Camberwell, Melbourne, VIC, AUS, 3123
Entropy Neurodynamics Ltd is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. The company's lead program is TRP-8803. TRP-8803 is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe.